Table 2.
Radiosensitization effects of Foretinib on ECA-109 xenograft model
| Treatment | Doubling time (Days) | Absolute Growth Delay (Days) | Normalized Growth Delay (Days) | Enhancement Factor |
|---|---|---|---|---|
| Control | 3.4±0.4 | |||
| Foretinib | 4.9±0.3 | 1.5±0.3 | ||
| IR | 5.7±0.8 | 2.3±0.8 | ||
| Foretinib+IR | 13.7±1.4 | 10.3±1.4 | 8.8±1.4 | 3.8(8.8/2.3) |
Absolute Growth Delay (Days), the doubling tumor time of treatment group minus that of control group;
Normalized Growth Delay (Days), the time of absolute growth delay of tumor in IR combined with foretinib group minus that of foretinib group.